28 October 2012
RPCI is one of the leading centers internationally for research on cancer immunotherapy "vaccines," approaches that use the body's own defense mechanisms to treat or prevent cancer. Center for Immunotherapy faculty members Thomas Schwaab, MD, PhD, Assistant Professor, Departments of Urology and Immunology, and Christopher Choi, PhD, Director of the Therapeutic Cell Production Facility, discuss this field and the scope of immunotherapy research at RPCI.